Article

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

2022-09-13

Abstract excerpt

There are considerable new data on mutation topography in persons with myelodysplastic syndromes (MDS). These data have been used to update conventional risk models such as the Revised International Prognostic Scoring System (IPSS-R). Whether the molecular IPSS (IPSS-M) which includes these data improves survival prediction accuracy is untested. To answer this question, we compared survival prediction accuracies o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c0dc0d2a-58b2-508e-be6e-ba8a2729d4e8
DOI: 10.21203/rs.3.rs-2046024/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromesDOI 10.21203/rs.3.rs-2046024/v1Read

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.Semantic proximity Read

Prognostic models in myelodysplastic syndromes.Semantic proximity Read

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes Defined by International Consensus ClassificationSemantic proximity Read

[Molecular international prognostic scoring system for myelodysplastic syndromes].Semantic proximity Read

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?Semantic proximity Read

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.Semantic proximity Read

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.Semantic proximity Read

Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.Semantic proximity Read

New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes.Semantic proximity Read

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read

Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.Semantic proximity Read